We have located links that may give you full text access.
Cognitive-Behavioral Intervention for Anxiety Associated with Food Allergy in a Clinical Sample of Children.
Annals of Allergy, Asthma & Immunology 2022 September 24
BACKGROUND: Multiple reviews have identified a lack of evidence-based treatments for excessive anxiety in the context of food allergy (FAA) as an unmet need.
OBJECTIVE: This study examined the feasibility, acceptability, and proof-of-concept of Food Allergy Bravery (FAB), a brief, novel, manualized cognitive behavioral-based intervention for anxiety in a clinical sample of children with FAA.
METHODS: Three cohorts of children (ages 8-12 years) with clinically impairing FAA and their parents were offered a course of FAB delivered in a group format. Ratings of anxiety severity and quality of life (QOL) were collected at pretreatment, posttreatment, and at 2-4 month follow-up.
RESULTS: All families offered treatment completed the full course of FAB, attended at least 5/6 active treatment sessions, and rated the intervention as highly satisfactory. All children were rated as very much improved or much improved on the Clinician Global Impression scale at posttreatment. Anxiety severity scores on the Scale of Food Allergy Anxiety (SOFAA) and the Scale of Child Anxiety-Related Emotional Disorders (SCARED) significantly declined per both child- and parent-report. Scores on the Food Allergy Quality of Life Questionnaire-Parent Form (FAQLQ-PF) were significantly improved. Gains were maintained at follow-up.
CONCLUSION: This is the first study of an outpatient manualized psychosocial treatment for FAA in a clinically ascertained sample of children. Findings provide initial evidence of feasibility, acceptability, and proof of concept for the FAB intervention protocol. Randomized controlled trials are needed.
OBJECTIVE: This study examined the feasibility, acceptability, and proof-of-concept of Food Allergy Bravery (FAB), a brief, novel, manualized cognitive behavioral-based intervention for anxiety in a clinical sample of children with FAA.
METHODS: Three cohorts of children (ages 8-12 years) with clinically impairing FAA and their parents were offered a course of FAB delivered in a group format. Ratings of anxiety severity and quality of life (QOL) were collected at pretreatment, posttreatment, and at 2-4 month follow-up.
RESULTS: All families offered treatment completed the full course of FAB, attended at least 5/6 active treatment sessions, and rated the intervention as highly satisfactory. All children were rated as very much improved or much improved on the Clinician Global Impression scale at posttreatment. Anxiety severity scores on the Scale of Food Allergy Anxiety (SOFAA) and the Scale of Child Anxiety-Related Emotional Disorders (SCARED) significantly declined per both child- and parent-report. Scores on the Food Allergy Quality of Life Questionnaire-Parent Form (FAQLQ-PF) were significantly improved. Gains were maintained at follow-up.
CONCLUSION: This is the first study of an outpatient manualized psychosocial treatment for FAA in a clinically ascertained sample of children. Findings provide initial evidence of feasibility, acceptability, and proof of concept for the FAB intervention protocol. Randomized controlled trials are needed.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Revascularization Strategy in Myocardial Infarction with Multivessel Disease.Journal of Clinical Medicine 2024 March 27
Clinical practice guidelines on the management of status epilepticus in adults: A systematic review.Epilepsia 2024 April 13
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app